Medical Condition News

RSS

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

Oxagen Limited, a drug discovery and development company specializing in inflammation, today announced that the recruitment for its double blind, randomised, placebo controlled Phase IIb clinical trial in asthma with OC000459, its lead oral CRTH2 (DP2) antagonist, has now been completed.

9 Dec 2009

Research study on breast cancer susceptibility in rats

Social isolation and stress appear to increase susceptibility to breast cancer in rats, a US study has suggested.

9 Dec 2009

Research article on Peliosis hepatis

Peliosis hepatis (PH) is a rare pathological entity. PH varies from minimal asymptomatic lesions to larger massive lesions that may present with cholestasis, liver failure, portal hypertension, avascular mass lesion, or even spontaneous rupture.

9 Dec 2009

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that the FDA has granted orphan drug designation to MOTORGRAFT™, a stem cell-derived motor neuron product, for the treatment of Spinal Muscular Atrophy (SMA).

9 Dec 2009

European markets for Parkinson's disease therapeutics to reach $2.28 billion in 2015

The Parkinson's disease therapeutics market in 2008 amounted to over $1 billion in the European Union (EU), which includes total sales of carbidopa/levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors and anticholinergics used for disease symptom relief.

9 Dec 2009

New findings may help restore vision in patients with corneal injury

Winston Whei-Yang Kao, PhD, professor of ophthalmology, along with other researchers in UC's ophthalmology department found that transplanting human umbilical mesenchymal stem cells into mouse models that lack the protein lumican restored the transparency of cloudy and thin corneas.

9 Dec 2009

GPEC receives unrestricted grant of $250,000 to study new treatments for breast cancer

Located at Vancouver General Hospital and a partner of the BC Cancer Agency, the Genetic Pathology Evaluation Centre, led by three prominent pathologists, is a recognized world leader in cancer research in the area of biomarker technology. Today, with an additional unrestricted grant of $250,000 from sanofi-aventis, GPEC is ready to make even more scientific breakthroughs.

9 Dec 2009

LCA and national organizations join hands to address lung cancer

Today, Lung Cancer Alliance (LCA) praised the growing coalition of national organizations joining LCA in its "call to action" to devise a better public health strategy to address the nation's most lethal cancer.

9 Dec 2009

Experts call on Europe's policy makers to take urgent action against preventable strokes

A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year

9 Dec 2009

Memgen announces positive clinical data of ISF35 with chemotherapy

Memgen announced today that positive data evaluating its active cellular immunotherapy product, ISF35, in combination with chemotherapy in resistant chronic lymphocytic leukemia (CLL) were presented December 7 during the 51st Annual Meeting of the American Society of Hematology (Abstract #376).

9 Dec 2009

MEP HG and heart experts discuss EU achievements in combating cardiovascular disease

Members of the European Parliament Heart Group (MEP HG) meet today (9 December), in Brussels, with the Cardiology profession and representatives of national Heart Foundations to evaluate the achievements at EU level in combating Cardiovascular Disease (CVD), and to reveal the need for further action.

9 Dec 2009

People living in deprived neighborhoods more likely to die from cancer and heart disease

Regardless of an individual's dietary and lifestyle risk factors, living in a poorer or more socioeconomically deprived neighborhood may increase a person's risk for death, according to data presented at the American Association for Cancer Research Conference on Frontiers in Cancer Prevention Research, held Dec. 6-9, 2009.

9 Dec 2009

Smokers taking the Respiragene test try to quit smoking, reveals study

Smokers who see their own personal risk of developing lung cancer after genetic-based testing show stronger intention and take more action on quitting smoking, according to clinical trial results presented to an American Association of Cancer Research conference.

9 Dec 2009

Statewide blood screening program identifies infants with T-cell lymphopenia

The testing of DNA from a statewide blood screening program for newborns in Wisconsin was able to identify infants with T-cell lymphopenia, a blood disorder that affects the child's immune system, a disease in which early identification is important, according to a study in the December 9 issue of JAMA.

9 Dec 2009

Ontario chiropractors offer tips to help ward off common seasonal injuries

With the season's first winter storm looming, Ontarians can expect to get quite a workout clearing the driveway - especially when you consider that a single shovelful of snow weighs 5 to 7 pounds. Improper shoveling can lead to minor strains and sore muscles, and can also cause more serious injuries.

9 Dec 2009

New regenerative therapies for heart disease being developed

Bioengineers from University of California, San Diego are developing new regenerative therapies for heart disease. The work could influence the way in which regenerative therapies for cardiovascular and other diseases are treated in the future.

9 Dec 2009

TGen and Scottsdale Healthcare test PHA-848125ac drug for thymic cancer

The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare.

9 Dec 2009

IQWiG's report on autologous stem cell transplantation for soft tissue sarcoma

Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some of the patient's own (autologous) stem cells are removed at a convenient time and generally re-implanted after a course of high-dose chemotherapy.

9 Dec 2009

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

Austin-based On-X® Life Technologies, Inc., manufacturers of the On-X® Prosthetic Heart Valve, announced today that it has entered into an exclusive worldwide license with the Cleveland Clinic for a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae.

9 Dec 2009

Comprehensive report details the prevalence, implications, costs of caregiving and demographics of caregivers

Caregiving is still mostly a woman's job and many women are putting their career and financial futures on hold as they juggle part-time caregiving and full-time job requirements.

9 Dec 2009

Medical Condition News

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

Research study on breast cancer susceptibility in rats

Research article on Peliosis hepatis

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

European markets for Parkinson's disease therapeutics to reach $2.28 billion in 2015

New findings may help restore vision in patients with corneal injury

GPEC receives unrestricted grant of $250,000 to study new treatments for breast cancer

LCA and national organizations join hands to address lung cancer

Experts call on Europe's policy makers to take urgent action against preventable strokes

Memgen announces positive clinical data of ISF35 with chemotherapy

MEP HG and heart experts discuss EU achievements in combating cardiovascular disease

People living in deprived neighborhoods more likely to die from cancer and heart disease

Smokers taking the Respiragene test try to quit smoking, reveals study

Statewide blood screening program identifies infants with T-cell lymphopenia

Ontario chiropractors offer tips to help ward off common seasonal injuries

New regenerative therapies for heart disease being developed

TGen and Scottsdale Healthcare test PHA-848125ac drug for thymic cancer

IQWiG's report on autologous stem cell transplantation for soft tissue sarcoma

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

Comprehensive report details the prevalence, implications, costs of caregiving and demographics of caregivers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News